An excellent day celebrating the Scarred Liver Project & discussing innovative collaborative future working to improve early diagnostic pathways & patient care #ParadigmShift ID LIVER Tim Guyler 💙 Rebecca Harris Mohsen Subhani NIHR Nottingham BRC ResearchNUH NottmBRCLiver&GI

Thanks to the inspiring speakers and everyone’s valuable contributions at today’s #scarredliverproject Shared Learning Day! Rebecca Harris Tim Guyler 💙 Stephen Wormall Change Grow Live NIHR Nottingham BRC ID LIVER

Excited to share the results of our study that will hopefully influence clinical practice. Journal of Hepatology NottmBRCLiver&GI. Thanks to all involved. Risk of liver fibrosis associated with long-term methotrexate therapy ... sciencedirect.com/science/articl…

Over 1000 patients are now participating in our study to improve early diagnosis of #LiverDisease Read about how the team are establishing mobile community clinics to assess people with increased risk 👇 research.cmft.nhs.uk/news-events/gr…

Hot take: Methotrexate does not cause liver fibrosis It’s ok to be cautious (periodic fibroscan). It’s ok to use MTX initiation as a trigger to look for fibrosis in at risk people (eg diabetes). But Time to turn the page pubmed.ncbi.nlm.nih.gov/36702175/ Edmond Atallah #livertwitter

Dr Huw Purssell was speaking with members of the public today at day 2 of the British Liver Trust #LoveYourLiver Roadshow in #Manchester. The roadshow travels the UK to help people check on their liver health, and take control of improving it

It's great to arrive at #EASLCongress in Vienna. Looking forward to the excellent programme ahead, including four oral presentations from the ID LIVER team

Excellent poster Edmond Atallah ! #easl2023 NottsLiver @ResearchNUH NIHR Nottingham BRC

🔬 Exciting Findings at #EASLCongress 2023! Karen Piper Hanley presents groundbreaking research on liver fibrosis at the General Session II. Her study, titled "An Integrative Multi-omic Approach Defines Therapeutic Pathways in Liver Fibrosis," revealed promising insights into

Impressive talk from karen Piper Hanley at #EASLCongress An integrative multi-omic approach to early diagnosis of #LiverFibrosis

Neil Guha discussing different pathways for stratifying #LiverDisease risk in primary care #EASLCongress

Results of “KLIFAD” trial showed. NITs-based biofeedback and alcohol lived experience. 📷 can improve engagement in alcohol services and supplement behavior change 📷 1 in 5 people had raised LSM Link: bit.ly/4437kjp Ramon Bataller Mark Beattie Rob Brierley Andrew Yeoman

Really pleased to receive this award for our participatory research project with Vocal & British Liver Trust to improve communication between clinicians and patients around liver disease risk BollyFit Active CIC Lucy Bennett karen Piper Hanley Varinder Athwal MFT Research and Innovation @LouiseBLT22 Data to Early Diagnosis and Precision Medicine

Spreading the word about #WorldHepatitisDay and offering Fibroscans at The Beacon Project Mansfield

Happy to see the ID LIVER project presenting important data on the impact of social depravation on liver disease at #TLM2023 🇬🇧Manchester project on patient detection via referral pathways

Awesome work Ellie !

Exciting news! Our proof of concept paper on using a machine learning model to risk stratify for significant liver disease in a primary care population is published! Check it out at jmai.amegroups.org/article/view/8…. Achieving success through collaborative teamwork! ID LIVER jiva.ai : AI made easy

We're thrilled to have worked with Vocal MFT Research and Innovation The University of Manchester to launch Liver Talks: Let’s Talk About Liver Disease. This free training resource for #healthcare professionals was created with patients & clinicians for @ID_Liver More: britishlivertrust.org.uk/talking-about-…